Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIF | 42.5 | 78 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIF | 42.5 | 54 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIF | 40.0 | 80 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIF | 44.5 | 70 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIF | 43.0 | 62 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | MIF | 44.0 | 51 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIF | 46.0 | 53 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | MIF | 47.0 | 69 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIF | 38.5 | 58 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | MIF | 40.0 | 41 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 255.5 | 62 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 53.0 | 62 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 34.0 | 69 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 43.0 | 74 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 230.0 | 61 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 59.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 31.0 | 50 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | MIF | 33.5 | 60 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 31.5 | 62 | |
N2645 | TNF-a | 100 | ng/mL | 4 | MIF | 34.0 | 52 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIF | 30.0 | 56 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | MIF | 29.5 | 52 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MIF | 35.5 | 34 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | MIF | 35.0 | 55 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MIF | 29.0 | 63 |